Effect of combined T- and B-cell depletion of allogeneic HLA-mismatched bone marrow graft on the magnitude and kinetics of Epstein–Barr virus load in the peripheral blood of bone marrow transplant recipients

Authors: Daorong Liu1; Charlotte Tammik2; Jie-Zhi Zou1; Ingemar Ernberg1; Maria G. Masucci1; Olle Ringden2; Victor Levitsky1

Source: Clinical Transplantation, Volume 18, Number 5, October 2004 , pp. 518-524(7)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Liu D, Tammik C, Zou J-Z, Ernberg I, Masucci MG, Ringden O, Levitsky V. Effect of combined T- and B-cell depletion of allogeneic HLA-mismatched bone marrow graft on the magnitude and kinetics of Epstein–Barr virus load in the peripheral blood of bone marrow transplant recipients.

Clin Transplant 2004 DOI: 10.1111/j.1399-0012.2004.00198.x

© Blackwell Munksgaard, 2004 Abstract:

Recipients of T-cell-depleted bone marrow (BM) transplants (BMT) frequently develop Epstein–Barr virus (EBV)-associated post-transplant lymphoproliferative disease (PTLD) preceded by a rapid and prominent increase of EBV load in the peripheral blood. The level of this increase positively correlates with the incidence of PTLD. Using a semiquantitative PCR assay we compared the blood levels of EBV-DNA in patients transplanted with either T-cell or T- and B-cell-depleted human leukocyte antigen (HLA)-mismatched BM grafts. Combined T- and B-cell depletion correlated with significantly lower maximal levels of EBV load, which were reached with slower kinetics. These data indicate that B-cell depletion of BM can be used for prophylaxis of PTLD in BM transplant recipients and can affect the long-term balance between EBV and its host.

Keywords: B-cell; Epstein–Barr virus; lymphoma

Document Type: Research article

DOI: 10.1111/j.1399-0012.2004.00198.x

Affiliations: 1: Microbiology and Tumor Biology Center 2: Department of Clinical Immunology and Center for Allogeneic Stem Cell Transplantation at Huddinge Hospital, Karolinska Institutet, Stockholm, Sweden

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$44.84 plus tax

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A